LuciEna 50mg is a targeted therapy used to treat acute
myeloid leukemia with IDH2 mutation. It helps restore normal blood cell
development and reduces cancer cell growth. This medicine is commonly
prescribed in specialized oncology centers across the United Kingdom, United
States, Australia, Singapore and Philippines. LuciEna offers a more focused
treatment approach improving disease management in patients who may not respond
to conventional therapies.
Active Ingredient
Enasidenib is an IDH2 inhibitor that targets mutated isocitrate dehydrogenase 2
enzyme. It belongs to a class of targeted anticancer agents designed to restore
normal cell differentiation.
Uses of LuciEna 50mg
• Treatment of acute myeloid leukemia
• Management of IDH2 mutation cancers
• Relief from abnormal blood cell growth
• Support for targeted leukemia therapy
How LuciEna 50mg Works
Enasidenib works by inhibiting the mutated IDH2 enzyme responsible for blocking
normal cell maturation. By restoring proper cell differentiation it helps
reduce the number of immature cancer cells and improves blood cell production.
How to Use LuciEna 50mg
- Take
once daily as directed
- Swallow
with water without crushing
- Continue
treatment as prescribed
Possible Side Effects
• Nausea
• Diarrhea
• Fatigue
• Elevated bilirubin
Precautions
• Monitor liver function
• Watch for differentiation syndrome
• Inform doctor about other treatments
Safety Information
Use LuciEna only under oncologist supervision. Regular monitoring is necessary
to manage side effects and assess treatment response.
Storage
• Store in a cool dry place
• Keep away from light
• Keep out of reach of children